Arterys Cardio DL vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Arterys (now part of Tempus)
VS
by Coreline Soft Co.

AI Verdict

Tool A specializes in cardiac MRI analysis, offering automated ventricle segmentations and advanced blood flow visualization. Tool B provides a broader platform for CT-based diagnostics, focusing on lung conditions like cancer and COPD, alongside coronary artery calcification scoring. While both contribute to cardiac imaging diagnostics, their primary modalities and specific analytical strengths differ, making them suitable for distinct clinical workflows.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is rapid, accurate, and automated analysis of cardiac MRI studies. This tool is ideal for cardiologists and radiologists seeking to significantly reduce interpretation time for ventricle segmentations and leverage advanced 4D Flow post-processing for detailed blood flow visualization and quantification. It excels in streamlining cardiac MRI workflows for enhanced diagnostic accuracy.

View Arterys Cardio DL →

Choose AVIEW if…

Choose AVIEW if you require a comprehensive AI platform for multi-modal thoracic CT analysis, encompassing lung cancer screening, COPD assessment, and coronary artery calcification scoring. This solution is best suited for radiologists who need to efficiently detect and characterize lung nodules, quantify emphysema, and perform cardiac risk stratification from CT scans within a single integrated workflow.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL AVIEW
Pricing Unknown Subscription; one-off payment
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL emphasizes 'rapid analysis (seconds vs. 30-60 minutes)' and 'editable automated contours,' directly addressing common pain points in cardiac MRI interpretation. These features suggest a highly efficient and user-controlled workflow for a specialized and time-consuming task. While AVIEW also focuses on workflow streamlining, Arterys's specific time-saving claims for a complex analysis are particularly compelling for usability.

Clinical Value

AVIEW

AVIEW offers a broader range of AI-powered diagnostic solutions across multiple critical conditions, including lung cancer, COPD, and coronary artery calcification, from standard CT scans. Its comprehensive analysis for lung nodules, emphysema, and CAC scoring addresses a wider spectrum of prevalent diseases and clinical needs. While Arterys provides deep, specialized analysis for cardiac MRI, AVIEW's broader impact across pulmonology and cardiology (CT) offers more widespread clinical utility.

Pricing & Value

AVIEW

AVIEW provides more transparency regarding its pricing model, offering both subscription and one-off payment options based on installations or users. This clarity allows potential customers to better understand and budget for the solution. Arterys, in contrast, only states 'contact for pricing,' which offers no immediate insight into its cost structure.

Enterprise Readiness

AVIEW

AVIEW offers superior deployment flexibility, supporting cloud-based, hybrid, local hardware, and virtualized solutions, which caters to diverse enterprise IT infrastructures and security requirements. Its explicit mention of integration with PACS/RIS/CIS further highlights its readiness for seamless incorporation into existing hospital workflows. While Arterys is cloud-based and vendor-agnostic, AVIEW's broader deployment options provide a significant advantage for large-scale enterprise adoption.

Innovation

Arterys Cardio DL

Arterys Cardio DL positions itself as 'The world's first internet platform for medical imaging,' indicating a pioneering approach to cloud-based AI in the field. Its advanced features like 4D Flow post-processing and Quantitative Delayed Enhancement analysis for cardiac MRI represent highly specialized and cutting-edge applications of AI. While AVIEW demonstrates innovation in its comprehensive CT analysis, Arterys's claim of foundational platform innovation and specialized cardiac MRI features gives it an edge in this dimension.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information from web searches offer specific details regarding the quality, scope, or accessibility of support and documentation for either Arterys Cardio DL or AVIEW. Both are established companies in the healthcare AI space, suggesting they likely offer standard enterprise-level support. Without comparative data, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL AVIEW
Name Arterys Cardio DL AVIEW
Company ARTERYS Coreline Soft Co.
Description Arterys Cardio DL is an FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Primary Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology
Key Features (Cardiology) Automated ventricle segmentations for cardiac MRI, 4D Flow post-processing for blood flow visualization and quantification, Quantitative Delayed Enhancement analysis Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), Automated segmentation of coronary arteries
Key Features (Other) Deep learning algorithms for image analysis, Cloud-based platform for accessibility and performance, Vendor-agnostic compatibility, Rapid analysis (seconds vs. 30-60 minutes), Editable automated contours AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), Emphysema quantification and low attenuation area (LAA) analysis, Automated segmentation of lung lobes, airways, vessels, 3D visualizations and comprehensive PDF reports, Workflow automation and integration with PACS/RIS/CIS, Follow-up registration and nodule matching for serial CT scans, Interstitial Lung Disease (ILD) pattern analysis (AVIEW Lung Texture)

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and AVIEW.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL focuses on automated ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement analysis from cardiac MRI scans. AVIEW provides comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.
Arterys Cardio DL is tailored for Cardiology and Radiology, specifically for cardiac MRI analysis. AVIEW serves Cardiology, Pulmonology, and Radiology, addressing conditions related to both the lungs and coronary arteries.
Arterys Cardio DL provides automated, editable ventricle segmentations, 4D Flow quantification, and quantitative delayed enhancement analysis. AVIEW offers detailed lung nodule characterization, emphysema quantification, comprehensive coronary artery calcium scoring, 3D visualizations, and comprehensive PDF reports.
AVIEW explicitly includes features for follow-up registration and nodule matching for serial CT scans, aiding in the monitoring of lung conditions. Arterys Cardio DL's description does not specifically detail longitudinal follow-up features, though its rapid analysis could support ongoing assessments.
AI Tool Finder
AI-powered search. Results may not be comprehensive.